Biotech

GenScript’s ProBio Pioneers Exciting Innovation in Immuno-Oncology

Strategic partnerships in immuno-cncology propel Innovation, highlighting ProBio’s role in the $3.3 billion LM-299 cancer therapy breakthrough.

Spotlight on Constructive Bio

The UK-based biotech company, specialising in synthetic genomics, recently obtained $58 million in Series A financing.

Exploring the UK's Rising Biotech: Bactobio

How Bactobio is revolutionizing biotechnology with breakthrough solutions for AMR and sustainable agriculture.

Advancing the Future of ADCs through Machine Learning: Lonza’s Synaffix and BigHat Biosciences Collaboration

The recent collaboration between Lonza’s Synaffix and BigHat Biosciences exemplifies the growing convergence of biotechnology with machine learning to produce next-generation cancer therapies.

CGT Manufacturing: A Comparative Analysis of APAC, EMEA, and NA Markets

We assess the intricate manufacturing landscapes of cell and gene therapies, highlighting the distinct capabilities, regulatory environments, and market dynamics of North America, Europe, the Middle East, Africa, and the Asia-Pacific region.

Astellas Pharma Invests $50 million in AviadoBio to Bolster Gene Therapy Offering

The pharmaceutical giant invests in AviadoBio, giving them an option to acquire the London-based biotech's gene therapy aimed at frontotemporal dementia (FTD).